Rheumatology treats musculoskeletal and autoimmune diseases, including arthritis, lupus, gout, and vasculitis.
We're Here to Help.
Get in Touch.
Send us all your questions or requests, and our expert team will assist you.
The Strategy of Disease Modification
The management of systemic sclerosis has evolved into a sophisticated, organ-specific strategy that integrates pharmacological intervention with rehabilitative and regenerative approaches. There is currently no single cure that reverses the disease entirely, but modern medicine offers potent tools to modify its course, manage symptoms, and prevent severe complications. The treatment philosophy follows a “treat to target” model, aiming to suppress inflammation, stabilize vascular function, and halt the progression of fibrosis. The therapeutic regimen is highly personalized, determined by the specific disease subtype (limited versus diffuse) and the organs involved.
Central to this strategy is the concept of vascular rescue. Since vascular injury initiates the disease, maintaining blood flow is critical. This involves aggressive vasodilator use. Calcium channel blockers are the first-line therapy for Raynaud’s phenomenon, relaxing the smooth muscles of the arterial wall. For more severe vascular ischemia or digital ulcers, phosphodiesterase type 5 inhibitors and endothelin receptor antagonists are employed. These advanced agents not only improve peripheral circulation but also serve as the cornerstone of treating pulmonary arterial hypertension, helping reduce strain on the right heart and improve exercise tolerance.
Immunosuppression and Antifibrotic Therapy
To address the autoimmune component, systemic immunosuppression is used, particularly in the early, active phase of diffuse disease, when inflammation is driving progression in the skin and lungs. Mycophenolate mofetil has emerged as the standard of care for scleroderma-related interstitial lung disease and cutaneous involvement. It works by inhibiting lymphocyte proliferation, effectively dampening the immune response with a relatively favorable side-effect profile compared to older agents.
For rapidly progressive disease, cyclophosphamide may be used as an induction therapy to gain quick control, followed by maintenance with milder agents. B-cell-depleting therapy with rituximab is showing promise in clinical trials for both skin and lung disease, targeting antibody-producing cells directly. Recently, the approval of nintedanib, a tyrosine kinase inhibitor with antifibrotic properties, has added a new dimension to treatment. Unlike immunosuppressants, this drug targets fibroblasts directly, inhibiting signaling pathways that drive collagen deposition. It is specifically indicated for slowing the decline of lung function in patients with scleroderma-associated interstitial lung disease.
Regenerative Interventions and Stem Cell Therapy
Regenerative medicine offers the greatest potential to alter the natural history of systemic sclerosis. Autologous Hematopoietic Stem Cell Transplantation (HSCT) is a procedure reserved for select patients with severe, rapidly progressive diffuse scleroderma who are at high risk of organ failure but have not yet developed irreversible damage. The protocol involves harvesting the patient’s own stem cells, administering high-dose chemotherapy to ablate the dysfunctional immune system, and then reinfusing the stem cells to reconstitute a new, naïve immune system. Clinical trials have demonstrated that HSCT can induce long-term remission and improve survival, although it carries significant risks that require expert management in specialized centers.
Less invasive regenerative options include adipose-derived mesenchymal stem cells. Autologous fat grafting is increasingly used to treat the fibrotic changes of the face and hands. The injected fat tissue provides volume but also contains a stromal vascular fraction rich in stem cells. These cells secrete angiogenic and trophic factors that improve the local microenvironment, leading to softer skin, improved mouth opening, and better vascularization. This “bio-revitalization” of the tissue represents a functional restoration that goes beyond cosmetic improvement.
Management of Gastrointestinal and Renal Complications
Effective management requires meticulous attention to the digestive and renal systems. Gastrointestinal complications are managed symptomatically to maintain nutrition and comfort. Proton pump inhibitors are prescribed at high doses to prevent esophageal scarring from acid reflux. Prokinetic agents are used to stimulate gut motility in patients with gastroparesis. For those with bacterial overgrowth, rotating courses of antibiotics can alleviate symptoms of malabsorption.
Renal protection is a non-negotiable aspect of care. The use of angiotensin-converting enzyme (ACE) inhibitors has dramatically altered the prognosis of scleroderma renal crisis. These drugs counteract the renin-induced spike in blood pressure. Patients are educated to monitor their blood pressure at home, as early initiation of ACE inhibitors is the only effective way to prevent permanent kidney damage during a crisis. Prophylactic use of these drugs in stable patients is generally avoided, as it may mask the early signs of a crisis.
Physical Therapy and Rehabilitation
Pharmacology alone cannot preserve function; it must be paired with physical rehabilitation. Fibrosis of the skin and tendons leads to progressive contractures and loss of mobility. A dedicated stretching and range-of-motion program is essential. Hand therapy helps maintain grip strength and dexterity. Mouth-stretching exercises are prescribed to prevent microstomia and to retain the ability to eat and perform dental care.
Occupational therapists play a vital role in teaching energy-conservation techniques and providing adaptive devices that help patients maintain independence despite hand deformities. Paraffin wax baths and heat therapy are often used before exercise to soften tissues and improve flexibility. The goal of rehabilitation is to oppose the forces of fibrosis mechanically, keeping the joints and tissues as mobile as possible while medical therapies take effect.
30 Years of Excellence
Trusted Worldwide
With patients from across the globe, we bring over three decades of medical
Book a Free Certified Online
Doctor Consultation
Reviews from 9,651
4,9
Worth a look
Was this article helpful?
We're Here to Help.
Get in Touch.
Send us all your questions or requests, and our expert team will assist you.
FREQUENTLY ASKED QUESTIONS
What is the role of mycophenolate mofetil in treating scleroderma?
While both treat joint and muscle problems, their focus differs.
- Rheumatologists are internal medicine specialists who focus on the medical management (using medication and lifestyle changes) of autoimmune and inflammatory conditions like Rheumatoid Arthritis and Lupus.
- Orthopedists are surgeons who focus on mechanical injuries and structural corrections, and who perform surgeries such as joint replacements.
How does autologous stem cell transplantation work for this disease?
This procedure involves collecting your own blood stem cells, using chemotherapy to wipe out the immune system that is attacking your body, and then returning your stem cells to rebuild a new, healthier immune system. It is an aggressive treatment aimed at “resetting” the disease in severe cases.
Can antifibrotic medications reverse existing lung scarring?
Current antifibrotic medications like nintedanib cannot remove scar tissue that has already formed. However, they are very effective at slowing down the rate of new scarring. The goal is to preserve the remaining lung function and prevent the condition from worsening.
Why are ACE inhibitors important for scleroderma patients?
ACE inhibitors are blood pressure medications that are specifically effective in treating scleroderma renal crisis. They block the hormone responsible for the dangerous spike in blood pressure and constriction of kidney blood vessels, saving the kidneys from failure if used immediately during a crisis.
Is fat grafting considered a cosmetic or medical procedure in scleroderma?
While it improves appearance, fat grafting is considered a medical and regenerative procedure in scleroderma. The stem cells in the fat help soften tight tissue, improve blood flow, and increase the mouth’s functional opening, which helps with eating and speaking.
